These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8562301)
1. Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population. Wanwimolruk S; Thou MR; Woods DJ Br J Clin Pharmacol; 1995 Aug; 40(2):166-9. PubMed ID: 8562301 [TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations. Wanwimolruk S; Bhawan S; Coville PF; Chalcroft SC Eur J Clin Pharmacol; 1998 Jul; 54(5):431-5. PubMed ID: 9754989 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic oxidative metabolism of proguanil in a Nigerian population. Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the polymorphic oxidation of debrisoquine and proguanil in a New Zealand Maori population. Wanwimolruk S; Pratt EL; Denton JR; Chalcroft SC; Barron PA; Broughton JR Pharmacogenetics; 1995 Aug; 5(4):193-8. PubMed ID: 8528265 [TBL] [Abstract][Full Text] [Related]
5. Evidence for the polymorphic oxidation of debrisoquine in the Thai population. Wanwimolruk S; Patamasucon P; Lee EJ Br J Clin Pharmacol; 1990 Feb; 29(2):244-7. PubMed ID: 2306417 [TBL] [Abstract][Full Text] [Related]
6. Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population. Basci NE; Bozkurt A; Kortunay S; Isimer A; Sayal A; Kayaalp SO Br J Clin Pharmacol; 1996 Dec; 42(6):771-3. PubMed ID: 8971434 [TBL] [Abstract][Full Text] [Related]
7. Debrisoquine and mephenytoin oxidation in Sinhalese: a population study. Weerasuriya K; Jayakody RL; Smith CA; Wolf CR; Tucker GT; Lennard MS Br J Clin Pharmacol; 1994 Nov; 38(5):466-70. PubMed ID: 7893590 [TBL] [Abstract][Full Text] [Related]
8. S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population. Basci NE; Brosen K; Bozkurt A; Isimer A; Sayal A; Kayaalp SO Br J Clin Pharmacol; 1994 Nov; 38(5):463-5. PubMed ID: 7893589 [TBL] [Abstract][Full Text] [Related]
9. The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study. Ward SA; Helsby NA; Skjelbo E; Brøsen K; Gram LF; Breckenridge AM Br J Clin Pharmacol; 1991 Jun; 31(6):689-92. PubMed ID: 1867963 [TBL] [Abstract][Full Text] [Related]
11. Effects of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in healthy volunteers. Somogyi AA; Reinhard HA; Bochner F Eur J Clin Pharmacol; 1996; 50(5):417-9. PubMed ID: 8839666 [TBL] [Abstract][Full Text] [Related]
12. Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. Kallio J; Lindberg R; Huupponen R; Iisalo E Br J Clin Pharmacol; 1988 Dec; 26(6):791-5. PubMed ID: 3242585 [TBL] [Abstract][Full Text] [Related]
13. Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population. Horai Y; Taga J; Ishizaki T; Ishikawa K Br J Clin Pharmacol; 1990 Jan; 29(1):111-5. PubMed ID: 2297455 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians. Kiivet RA; Svensson JO; Bertilsson L; Sjöqvist F Pharmacol Toxicol; 1993 Feb; 72(2):113-5. PubMed ID: 8474964 [TBL] [Abstract][Full Text] [Related]
15. Debrisoquine oxidation polymorphism in a Tasmanian population. Veronese ME; McLean S Eur J Clin Pharmacol; 1991; 40(5):529-32. PubMed ID: 1884730 [TBL] [Abstract][Full Text] [Related]
16. Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population. Vincent-Viry M; Muller J; Fournier B; Galteau MM; Siest G Clin Chem; 1991 Mar; 37(3):327-32. PubMed ID: 2004438 [TBL] [Abstract][Full Text] [Related]
18. The multiple dose pharmacokinetics of proguanil. Helsby NA; Edwards G; Breckenridge AM; Ward SA Br J Clin Pharmacol; 1993 Jun; 35(6):653-6. PubMed ID: 8329294 [TBL] [Abstract][Full Text] [Related]
19. Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients. Spina E; Campo GM; Calandra S; Caputi AP; Carrillo JA; Benitez J Pharmacol Res; 1992 Jan; 25(1):43-50. PubMed ID: 1738757 [TBL] [Abstract][Full Text] [Related]